SI-BONE, Inc. (SIBN)
SI-BONE, Inc. (SIBN) from its SEC filings: 2025 revenue $200.9 million (+20% vs the year before), net margin -9%, free cash flow -$9.1 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Revenue (2025) | $200.9 million |
| Revenue growth | +20% |
| Net income | -$18.9 million |
| Net margin | -9.4% |
| Free cash flow | -$9.1 million |
| Diluted EPS | $-0.44 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +15% |
| Cash | $33.1 million |
| Long-term debt | $35.6 million |
| Share count, 1 year | +4% |
| Fundamentals check | Mixed fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.